Refined By:
Author:  Marcovina, Santica M

Results 1-7 of 7 (Search time: 0.004 seconds).

Select some or all of the publications and click the Endnote Export button to be provided with a RIS export file of these publications.

Publication DateTitleAuthor(s)Date Added
1Jun-2022PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentrationYing, Qidi; Chan, Dick C; Pang, Jing; Marcovina, Santica M; Barrett, Peter Hugh R ; Watts, Gerald F12-May-2022
21-Jun-2020PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)Watts, Gerald F; Chan, Dick C; Pang, Jing; Ma, Louis; Ying, Qidi; Aggarwal, Shashi; Marcovina, Santica M; Barrett, P Hugh R 16-Aug-2021
3Dec-2019Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) ConcentrationMa, Louis; Chan, Dick C; Ooi, Esther M M; Marcovina, Santica M; Barrett, P Hugh R ; Watts, Gerald F18-Aug-2021
42-Apr-2019Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering TherapyChan, Dick C; Watts, Gerald F; Coll, Blai; Wasserman, Scott M; Marcovina, Santica M; Barrett, P Hugh R 16-Aug-2021
514-Jul-2018Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kineticsWatts, Gerald F; Chan, Dick C; Somaratne, Ransi; Wasserman, Scott M; Scott, Rob; Marcovina, Santica M; Barrett, P Hugh R 11-Aug-2021
6Apr-2016Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)Diffenderfer, Margaret R; Lamon-Fava, Stefania; Marcovina, Santica M; Barrett, P Hugh R ; Lel, Julian; Dolnikowski, Gregory G; Berglund, Lars; Schaefer, Ernst J9-Mar-2022
7Dec-2015Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp(a) and ApoB-100-Containing Lipoproteins in Statin-Treated Men with Type 2 Diabetes MellitusOoi, Esther M; Watts, Gerald F; Chan, Dick C; Pang, Jing; Tenneti, Vijay S; Hamilton, Sandra J; McCormick, Sally P; Marcovina, Santica M; Barrett, P Hugh R 17-May-2022

Full Name
Barrett, Hugh
Variants
P H Barrett
Barrett, P Hugh R
Barrett, P H R
Barrett, Hugh P R
Barrett, Peter Hugh
 
UNE Researcher ID
une-id:pbarret6
 
Position Title
Associate Dean Research
 
 
Google Scholar profile key
7OtfUxcAAAAJ
Biography
Hugh has been a biomedical research fellow for much of his career, supported via the NIH, National Heart Foundation, NHMRC and industry. His research has focussed on lipid and lipoprotein metabolism combined with mathematical modelling, using compartment models. His research career began at the BakerIDI, moved to the University of Washington and more recently the University of Western Australia, where he was also the Associate Dean, Research in the Faculty of Health and Medical Sciences. His research has contributed to understanding lipid and lipoprotein metabolism in a variety of human dyslipidemic states and under various interventions designed to reduce cardiovascular disease burden. Using tracer methodologies his research has described the mechanism of action of statins, fibrates, CETP inhibitors, new PPAR agonists and other lipid lowering agents on lipoprotein kinetics, primarily in subjects with the metabolic syndrome. In addition, his research and modelling of tracer data in human, animal and in vitro systems has provided insight into the pathways that are responsible for the regulation of lipid metabolism. His present role is focussed on building research capacity, quality, output and outcomes in the Faculty of Medicine and Health at UNE.
 
Discipline
Faculty of Medicine and Health
 
Faculty
Faculty of Medicine and Health
Honorific
Professor
 
Surname
Barrett
loader Loading... 2 0 5 0 false
Given Name
Peter
 
Middle Name
Hugh
Preferred Given Name
Hugh
School/Department
Faculty of Medicine and Health
loader Loading... 3 0 5 0 false